Stein Jeffrey
SEC Form 4 insider trading activity
Stein Jeffrey has filed 5 SEC Form 4 filings (24 transaction rows) across 2 companies, including IDYA, CDTX, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Mar 2, 2026.
On the most recent filing, Stein Jeffrey is listed as Director at IDEAYA Biosciences, Inc. Inside the rolling window, Stein Jeffrey reported 5 open-market purchases totaling $2.0M in IDYA and CDTX and no open-market sales. The largest disclosed transaction in the window is a purchase of 50,000 IDYA shares on Mar 2, 2026, worth $1.6M.
Companies traded
Other insiders at IDYA
Insider Buying
$2.0M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Stein Jeffrey made?
Stein Jeffrey has filed 5 SEC Form 4 filings (24 transaction rows) across 2 companies, including IDYA, CDTX since 2025.
Which companies does Stein Jeffrey trade?
Stein Jeffrey has filed SEC Form 4 disclosures for 2 companies, including IDYA, CDTX.
When was Stein Jeffrey's most recent SEC Form 4 filing?
Stein Jeffrey's most recent SEC Form 4 filing on Tracefour is dated Mar 2, 2026.
What is Stein Jeffrey's total buy and sell value in the current window?
Inside the rolling retention window, Stein Jeffrey bought $2.0M and sold $0 based on SEC Form 4 filings.
What was Stein Jeffrey's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 50,000 IDYA shares on 2026-03-02, worth $1.6M, per SEC Form 4 filings.